What is the share price of Shalby Ltd (SHALBY) today?
The share price of SHALBY as on 5th December 2025 is ₹197.69. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Shalby Ltd (SHALBY) share?
The past returns of Shalby Ltd (SHALBY) share are- Past 1 week: -4.59%
- Past 1 month: -16.67%
- Past 3 months: 2.25%
- Past 6 months: 9.54%
- Past 1 year: -17.56%
- Past 3 years: 34.16%
- Past 5 years: 84.75%
What are the peers or stocks similar to Shalby Ltd (SHALBY)?
The peers or stocks similar to Shalby Ltd (SHALBY) include:What is the market cap of Shalby Ltd (SHALBY) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Shalby Ltd (SHALBY) is ₹2152.76 Cr as of 5th December 2025.What is the 52 week high and low of Shalby Ltd (SHALBY) share?
The 52-week high of Shalby Ltd (SHALBY) is ₹274.70 and the 52-week low is ₹177.25.What is the PE and PB ratio of Shalby Ltd (SHALBY) stock?
The P/E (price-to-earnings) ratio of Shalby Ltd (SHALBY) is 346.10. The P/B (price-to-book) ratio is 2.16.Which sector does Shalby Ltd (SHALBY) belong to?
Shalby Ltd (SHALBY) belongs to the Health Care sector & Hospitals & Diagnostic Centres sub-sector.How to buy Shalby Ltd (SHALBY) shares?
You can directly buy Shalby Ltd (SHALBY) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Shalby Ltd
SHALBY Share Price
SHALBY Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
SHALBY Performance & Key Metrics
SHALBY Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 482.68 | 2.16 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 36.94 | 5.83 | 0.58% |
from 1 analyst
Price Upside
Earnings Growth
Rev. Growth
SHALBY Company Profile
Shalby Limited operates a multi-specialty chain of hospitals. Its hospitals are tertiary care hospitals, which offer quaternary healthcare services
SHALBY Sentiment Analysis
SHALBY Sentiment Analysis
SHALBY Stock Summary · June 2025
In Q4 FY '25, the company reported an 8.4% increase in consolidated revenue, yet faced significant declines in EBITDA and Profit Before Tax, primarily due to rising doctor costs and strategic investments in its hospital business. Despite these challenges, management remains optimistic about future growth, particularly in the implant sector and the Sanar Hospital, which is expected to return to EBITDA positivity. The company is enhancing operational efficiencies and expanding its market presence, particularly in high-margin regions like the U.S. and Japan, while addressing stagnation in its home care segment. Investor sentiment reflects cautious optimism, contingent on improved financial predictability and effective communication regarding performance metrics. Overall, the strategic focus on quality, operational excellence, and market expansion positions the company for potential long-term growth.
SHALBY Stock Growth Drivers
SHALBY Stock Growth Drivers
7Strong Financial Performance
Shalby Limited has reported significant financial achievements, including a consolidated revenue of INR 270 crores
Operational Efficiency and Growth in Implant Business
Shalby MedTech has made strides in operational efficiency, achieving improved gross margins through supply chain
SHALBY Stock Challenges
SHALBY Stock Challenges
5Declining EBITDA and Profit Margins
Shalby Limited has reported a significant decline in EBITDA, with Q4 FY '25 EBITDA dropping
Underperformance of Key Segments
The company has faced challenges across its three main segments: the stand-alone health hospital business,
SHALBY Forecast
SHALBY Forecasts
Price
Revenue
Earnings
SHALBY Share Price Forecast
SHALBY Share Price Forecast
All values in ₹
All values in ₹
SHALBY Company Revenue Forecast
SHALBY Company Revenue Forecast
All values in ₹ Thousand cr.
All values in ₹ Thousand cr.
SHALBY Stock EPS (Earnings Per Share) Forecast
SHALBY Stock EPS (Earnings Per Share) Forecast
All values in ₹
All values in ₹
SHALBY
SHALBY
Income
Balance Sheet
Cash Flow
SHALBY Income Statement
SHALBY Income Statement
| Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 330.52 | 388.00 | 471.52 | 504.22 | 439.96 | 711.37 | 827.44 | 953.18 | 1,114.56 | 1,144.60 | ||||||||||
| Raw Materials | 36.70 | 39.68 | 39.85 | 52.80 | 34.30 | 153.38 | 104.63 | 108.21 | 196.61 | 984.49 | ||||||||||
| Power & Fuel Cost | 7.59 | 9.43 | 12.66 | 12.98 | 12.31 | 14.49 | 16.25 | 19.70 | 22.46 | |||||||||||
| Employee Cost | 38.90 | 45.08 | 64.60 | 65.50 | 56.96 | 114.74 | 143.64 | 155.44 | 184.58 | |||||||||||
| Selling & Administrative Expenses | 17.58 | 20.56 | 19.59 | 21.04 | 13.61 | 36.89 | 61.30 | 66.75 | 89.12 | |||||||||||
| Operating & Other expenses | 151.51 | 184.31 | 242.07 | 251.75 | 226.39 | 262.32 | 340.92 | 405.03 | 459.46 | |||||||||||
| EBITDA | 78.24 | 88.94 | 92.75 | 100.15 | 96.39 | 129.55 | 160.70 | 198.05 | 162.33 | 160.11 | ||||||||||
| Depreciation/Amortization | 16.70 | 22.86 | 33.17 | 36.02 | 36.80 | 42.87 | 48.09 | 52.24 | 65.76 | 66.44 | ||||||||||
| PBIT | 61.54 | 66.08 | 59.58 | 64.13 | 59.59 | 86.68 | 112.61 | 145.81 | 96.57 | 93.67 | ||||||||||
| Interest & Other Items | 11.04 | 12.37 | 9.18 | 7.41 | 4.54 | 7.53 | 10.56 | 17.62 | 40.84 | 40.35 | ||||||||||
| PBT | 50.50 | 53.71 | 50.40 | 56.72 | 55.05 | 79.15 | 102.05 | 128.19 | 55.73 | 53.32 | ||||||||||
| Taxes & Other Items | 20.80 | 14.35 | 18.73 | 29.14 | 12.66 | 25.02 | 34.35 | 44.12 | 49.51 | 48.86 | ||||||||||
| Net Income | 29.70 | 39.36 | 31.67 | 27.58 | 42.39 | 54.13 | 67.70 | 84.07 | 6.22 | 4.46 | ||||||||||
| EPS | 3.40 | 4.03 | 2.93 | 2.55 | 3.92 | 5.01 | 6.29 | 7.83 | 0.58 | 0.41 | ||||||||||
| DPS | 0.00 | 0.00 | 0.50 | 0.50 | 1.00 | 1.00 | 1.20 | 1.20 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.17 | 0.20 | 0.25 | 0.20 | 0.19 | 0.15 | 0.00 | 0.00 |
SHALBY Company Updates
Investor Presentation
SHALBY Stock Peers
SHALBY Past Performance & Peer Comparison
SHALBY Past Performance & Peer Comparison
Health CareHospitals & Diagnostic Centres
Valuation
Technical
Forecast
| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Shalby Ltd | 346.10 | 2.16 | — |
| Max Healthcare Institute Ltd | 98.00 | 11.24 | 0.14% |
| Apollo Hospitals Enterprise Ltd | 71.61 | 9.33 | 0.18% |
| Fortis Healthcare Ltd | 86.64 | 7.32 | 0.11% |
SHALBY Stock Price Comparison
Compare SHALBY with any stock or ETFSHALBY Holdings
SHALBY Shareholdings
SHALBY Promoter Holdings Trend
SHALBY Promoter Holdings Trend
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant
SHALBY Institutional Holdings Trend
SHALBY Institutional Holdings Trend
In last 3 months, retail holding in the company has almost stayed constant
In last 3 months, foreign institutional holding of the company has almost stayed constant
SHALBY Shareholding Pattern
SHALBY Shareholding Pattern
SHALBY Shareholding History
SHALBY Shareholding History
Mutual Funds Invested in SHALBY
Mutual Funds Invested in SHALBY
No mutual funds holding trends are available
Top 2 Mutual Funds holding Shalby Ltd
| Funds (Top 2) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 0.0004% | Percentage of the fund’s portfolio invested in the stock 0.05% | Change in the portfolio weight of the stock over the last 3 months 0.01% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 100/124 (-3) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.0001% | Percentage of the fund’s portfolio invested in the stock 0.00% | Change in the portfolio weight of the stock over the last 3 months 0.00% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 978/1023 (-20) |
Compare 3-month MF holding change on Screener
smallcases containing SHALBY stock
smallcases containing SHALBY stock
Looks like this stock is not in any smallcase yet.
SHALBY Events
SHALBY Events
SHALBY Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
SHALBY Dividend Trend
No dividend trend available
SHALBY Upcoming Dividends
SHALBY Upcoming Dividends
No upcoming dividends are available
SHALBY Past Dividends
SHALBY Past Dividends
Cash Dividend
Ex DateEx DateSep 19, 2024
Dividend/Share
₹1.20
Ex DateEx Date
Sep 19, 2024
Cash Dividend
Ex DateEx DateAug 8, 2023
Dividend/Share
₹1.20
Ex DateEx Date
Aug 8, 2023
Cash Dividend
Ex DateEx DateSep 19, 2022
Dividend/Share
₹1.00
Ex DateEx Date
Sep 19, 2022
Cash Dividend
Ex DateEx DateSep 17, 2021
Dividend/Share
₹1.00
Ex DateEx Date
Sep 17, 2021
Cash Dividend
Ex DateEx DateSep 4, 2020
Dividend/Share
₹0.50
Ex DateEx Date
Sep 4, 2020
SHALBY Stock News & Opinions
SHALBY Stock News & Opinions
Net profit of Shalby rose 147.49% to Rs 8.39 crore in the quarter ended September 2025 as against Rs 3.39 crore during the previous quarter ended September 2024. Sales rose 6.69% to Rs 285.43 crore in the quarter ended September 2025 as against Rs 267.54 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales285.43267.54 7 OPM %14.5812.20 - PBDT36.4430.55 19 PBT19.0713.70 39 NP8.393.39 147 Powered by Capital Market - Live
Shalby will hold a meeting of the Board of Directors of the Company on 13 November 2025.Powered by Capital Market - Live
Despite today's dip, the stock has risen 43.66% in the past three months and 28.26% over six months. On a one-year basis, however, the scrip remains down 7.55%. Shalby operates 11 multispecialty tertiary hospitals and 5 orthopedic centers under the Shalby Orthopedics Center of Excellence (SOCE) across India, with a total capacity of over 2,200 beds. The company has also diversified into knee and hip implant manufacturing in the US. On a consolidated basis, net profit of Shalby declined 43.04% to Rs 8.92 crore while net sales rose 6.29% to Rs 296.43 crore in Q1 June 2025 over Q1 June 2024. Powered by Capital Market - Live
Shalby announced that the Annual General Meeting(AGM) of the company will be held on 29 September 2025.Powered by Capital Market - Live
Net profit of Shalby declined 43.04% to Rs 8.92 crore in the quarter ended June 2025 as against Rs 15.66 crore during the previous quarter ended June 2024. Sales rose 6.29% to Rs 296.43 crore in the quarter ended June 2025 as against Rs 278.89 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales296.43278.89 6 OPM %14.0116.21 - PBDT39.1746.79 -16 PBT22.6530.41 -26 NP8.9215.66 -43 Powered by Capital Market - Live
Shalby will hold a meeting of the Board of Directors of the Company on 13 August 2025.Powered by Capital Market - Live
Shalby Academy (a unit of Shalby) has entered into a Memorandum of Understanding (MoU) with Shree Vaishnav Vidyapeeth Vishwavidyalaya (SVVV), Indore. This collaboration aims to launch undergraduate and postgraduate programs in Healthcare and Hospital Management. Under this initiative, SVVV will offer full']time BBA and MBA programs in Healthcare & Hospital Management at its Indore campus. Admissions for the first intake are set to begin shortly. Powered by Capital Market - Live
Net loss of Shalby reported to Rs 11.02 crore in the quarter ended March 2025 as against net profit of Rs 16.60 crore during the previous quarter ended March 2024. Sales rose 8.46% to Rs 264.89 crore in the quarter ended March 2025 as against Rs 244.23 crore during the previous quarter ended March 2024. For the full year,net profit declined 92.60% to Rs 6.22 crore in the year ended March 2025 as against Rs 84.08 crore during the previous year ended March 2024. Sales rose 16.41% to Rs 1086.96 crore in the year ended March 2025 as against Rs 933.75 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales264.89244.23 8 1086.96933.75 16 OPM %7.8715.92 -12.2018.96 - PBDT15.4937.38 -59 121.49180.44 -33 PBT-0.7421.78 PL 55.73128.19 -57 NP-11.0216.60 PL 6.2284.08 -93 Powered by Capital Market - Live
Shalby will hold a meeting of the Board of Directors of the Company on 29 May 2025.Powered by Capital Market - Live
The domestic equity benchmarks traded with substantial gains in early afternoon trade, following gains in Asian markets. This came after the U.S. paused its planned tariffs on Canada and Mexico, which helped alleviate concerns about a potential global trade war. The Nifty traded above the 23,550 mark. Metal shares advanced after declining in past two consecutive trading sessions. At 12:30 IST, the barometer index, the S&P BSE Sensex, rallied 741.66 points or 0.97% to 77,928.40. The Nifty 50 index advanced 214.70 points or 0.92% to 23,575.75. In the broader market, the S&P BSE Mid-Cap index rose 0.78% and the S&P BSE Small-Cap index added 0.57%. The market breadth was strong. On the BSE, 2,317 shares rose and 1,428 shares fell. A total of 164 shares were unchanged. Derivatives: The NSE's India VIX, a gauge of the market's expectation of volatility over the near term, rallied 3.53% to 14.86. The Nifty 27 February 2025 futures were trading at 23,644.75, at a premium of 69 points as compared with the spot at 23,575.75. The Nifty option chain for the 29 February 2024 expiry showed maximum Call OI of 54 lakh contracts at the 24,000 strike price. Maximum put OI of 61.8 lakh contracts were seen at 23,000 strike price. Buzzing Index: The Nifty Metal index gained 1.58% to 8,283.60. The index fell 2.91% in past two consecutive trading sessions. Vedanta (up 3.52%), Jindal Stainless (up 3.03%), Steel Authority of India (up 2.74%), National Aluminium Company (up 2.53%), Hindustan Copper (up 2.45%), NMDC (up 2.22%), Hindalco Industries (up 2.17%), Ratnamani Metals & Tubes (up 1.81%), Welspun Corp (up 1.52%) and Adani Enterprises (up 1.05%) advanced. Stocks in Spotlight: Shalby slipped 4.17% after the company reported a consolidated net loss of Rs 1.81 crore for Q3 FY25, compared to a net profit of Rs 19.07 crore posted in Q3 FY24. However, revenue from operations jumped 27.6% YoY to Rs 275.63 crore in the quarter ended 31 December 2024. NLC India rallied 9.92% after the company's consolidated net profit surged 166.79% to Rs 668.09 crore on 39.41% rise in revenue from operations to Rs 4,411.41 crore in Q3 FY25 over Q3 FY24. Powered by Capital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 17.19%, vs industry avg of 13.4%
Over the last 5 years, market share increased from 1.21% to 1.4%
Over the last 5 years, net income has grown at a yearly rate of -25.76%, vs industry avg of 42.46%